VAERS Explorer
Back to explore

Report #2838980

Received Apr 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
61 yrs
State
NC
Recovered
Not recovered
Vaccinated
Jan 24, 2025
Onset
Jan 25, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Pain in extremity

Symptom narrative

soreness on her left arm; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included hydrochlorothiazide. On 24-JAN-2025, the patient received the 1st dose of Shingrix. On 25-JAN-2025, 1 days after receiving Shingrix, the patient experienced pain in arm (Verbatim: soreness on her left arm). The outcome of the pain in arm was not resolved. It was unknown if the reporter considered the pain in arm to be related to Shingrix. It was unknown if the company considered the pain in arm to be related to Shingrix. Additional Information: GSK receipt date: 28-APR-2025 The patient reported that she experiencing soreness on her left arm after receiving the first dose of Shingrix vaccine. The batch number and expiry date was unknown.

Other medications

HYDROCHLOROTHIAZIDE